Long-term follow-up after tight control of blood pressure in type 2 diabetes

Holman, Rury R., Paul, Sanjoy K., Bethel, M. Angelyn, Neil, H. Andrew W., Matthews, David R.·2008·New England Journal of Medicine
DOI 10.1056/nejmoa0806359

Cited by (761)

Items 401–500 of 761

  1. Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus
    Kazuya Fujihara, Hirohito Sone · 2018 · Annals of Vascular Diseases
  2. Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk
    Eirik Olsen, Björn Holzhauer, Stevo Julius, Sverre Erik Kjeldsen, Anne Cecilie K. Larstorp, Giuseppe Mancia, Maria H. Mehlum, Rune Mo, Morten Rostrup, Camilla Lund Søraas et al. · 2021 · Blood Pressure
  3. Benefit of Blood Pressure Control in Diabetic Patients
    Ulrich Kintscher · 2015 · Current Hypertension Reports
  4. Benefits of ACE Inhibitors in Diabetes
    Maria E. Ramos‐Niño, Steven R. Blumen · 2009 · Clinical Medicine Therapeutics
  5. La protection cardiovasculaire du patient diabétique avec maladie rénale chronique et cas particulier de l’insuffisance rénale chronique terminale du sujet âgé
    Philippe Zaoui, Thierry P. Hannedouche, Christian Combe · 2017 · Néphrologie & Thérapeutique
  6. Chronic Complications of Diabetes: Prevalence, Prevention, and Management
    Ilias N. Migdalis · 2024 · Journal of Clinical Medicine
  7. Diabetes and cardiovascular disease
    Oliver Schnell, Eberhard Standl · 2010 · Clinical Research in Cardiology Supplements
  8. Glycemic effects of vildagliptin and metformin combination therapy in I ndian patients with type 2 diabetes: An observational study (印度2型糖尿病患者使用维格列汀与二甲双胍联合治疗对血糖的影响：一项观察性研究)
    Sanjay Chatterjee, Sudip Chatterjee · 2013 · Journal of Diabetes
  9. Impact of a quality improvement intervention on provider adherence to recommended standards of care for adults with type 2 diabetes mellitus
    Marie Umar-Kamara, Kimberly Adams Tufts · 2013 · Journal of the American Association of Nurse Practitioners
  10. Restaging insulin therapy for patients with type 2 diabetes
    Alan J. Garber · 2009 · Diabetes Obesity and Metabolism
  11. Focusing on Cardiovascular Disease in Type 2 Diabetes Mellitus: An Introduction to Bromocriptine QR
    David S.H. Bell · 2012 · Postgraduate Medicine
  12. A cluster randomized controlled trial of the effectiveness and cost-effectiveness of Intermediate Care Clinics for Diabetes (ICCD): study protocol for a randomized controlled trial
    Natalie Armstrong, Darrin L. Baines, Richard Baker, Richard Crossman, Melanie Jane Davies, Ainsley Hardy, Kamlesh K. Khunti, Sudhesh Kumar, Joseph Paul O’Hare, Neil T. Raymond et al. · 2012 · Trials
  13. Prognostic significance of home pulse pressure for progression of diabetic nephropathy: KAMOGAWA-HBP study
    Noriyuki Kitagawa, Emi Ushigome, Shinobu Matsumoto, Chikako Oyabu, Hidetaka Ushigome, Isao Yokota, Mai Asano, Muhei Tanaka, Masahiro Yamazaki, Michiaki Fukui · 2018 · Hypertension Research
  14. Fighting diabetic foot ulcers—The diabetologist: A king maker of the fight
    Laura Nigi, Cecilia Fondelli, Gianmarco de DONATO, Giancarlo Palasciano, Carlo Setacci, Francesco Dotta · 2018 · Seminars in Vascular Surgery
  15. Wytyczne ESC dotyczące cukrzycy, stanu przedcukrzycowego i chorób układu sercowo- -naczyniowego opracowane we współpracy z EASD
    ESC EASD · 2013 · Kardiologia Polska
  16. Primary prevention of heart failure: what is the evidence?
    Carla Sueta Dupree · 2009 · Current Opinion in Cardiology
  17. High-risk diabetic nephropathy patients: The outcome of evidence-based clinical practice in an outpatient clinic
    Helen Slade, Sheila Williams, Patrick John Manning, Robert James Walker · 2011 · Diabetes Research and Clinical Practice
  18. The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial
    Sarah H. Wild, Janet Hanley, Steff C. Lewis, John A. McKnight, Lucy B. McCloughan, Paul L. Padfield, Mary Paterson, Hilary Pinnock, Brian McKinstry · 2013 · Trials
  19. Baseline patient profiling and three-year outcome data after metabolic surgery at a South African centre of excellence
    Maria‐Terésa van der Merwe, Gary Fetter, Sudha Naidoo, Renata Wilson, Nicola Drabble, David Gonçalves, Zubeida Mahomedy · 2015 · Journal of Endocrinology Metabolism and Diabetes of South Africa
  20. Association Between Chlorthalidone Treatment of Systolic Hypertension and Long-term Survival
    W.J. Elliott · 2012 · Yearbook of Cardiology
  21. Importance of intensive blood pressure control in type 2 diabetes: Mechanisms, treatments and current guidelines
    Michel Marre · 2020 · Diabetes Obesity and Metabolism
  22. Legacy Effect in the Treatment of Hypertension: Persistent Cardiovascular Protection after Conclusion of Randomized Clinical Trials in Hypertension
    Giovanna Gallo, Allegra Battistoni, Roberta Coluccia, Giuliano Tocci, Massimo Volpe · 2019 · Current Hypertension Reports
  23. [United Kingdom Prospective Diabetes Study (UKPDS): 10 years later].
    André Jacques Scheen, Nicolas Paquot, P J Lefebvre · 2008 · PubMed
  24. Changes in diabetes mortality rate in Costa Rica 2007–2017
    José G. Jiménez-Montero, Mayra Villegas-Barakat · 2021 · Diabetes Research and Clinical Practice
  25. Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease
    Mark Shipeng Yu, David A Folt, Christopher Anson Drummond, Steven T. Haller, Emily L. Cooper, Pamela S. Brewster, Kaleigh L. Evans, Christopher J. Cooper · 2014 · Current Atherosclerosis Reports
  26. Evaluation of patients with coronary artery disease for major modifiable risk factors for ischemic heart disease.
    Mohammad Zahidullah, Muhammad Aasim, Ihsanullah Khan, Hamza Zahid Ullah Muhammadzai, Mumtaz Anwar Shah, Niaz Ali, Amir Mohammad, Azeem Muzahir, Muhammad Shafi Rehman · 2012 · PubMed
  27. Complex diabetes screening guidelines for high-risk adolescent Aboriginal Australians: a barrier to implementation in primary health care
    Andreana Manifold, David N. Atkinson, Julia V. Marley, Lydia Scott, Gavin Cleland, Paula Edgill, Sally Singleton · 2019 · Australian Journal of Primary Health
  28. Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Jack Wei Chieh Tan, David Sim, Junya Ako, Wael A. Almahmeed, Mark Emmanuel Cooper, Jamshed J Dalal, Chaicharn Deerochanawong, David Wei Chun Huang, Sofian Johar, Upendra Kaul et al. · 2021 · European Cardiology Review
  29. Clinical Characteristics and Major Adverse Cardiovascular Events in Diabetic and Non-Diabetic Patients with Vasospastic Angina
    Hiroki Teragawa, Yuko Uchimura, Chikage Oshita, Yu Hashimoto, Shuichi Nomura · 2024 · Diabetes Metabolic Syndrome and Obesity
  30. Blood pressure control among patients with hypertension and newly diagnosed diabetes
    Neesha N. Choma, Marie R. Griffin, Lisa A. Kaltenbach, Robert A. Greevy, Christianne L. Roumie · 2011 · Diabetic Medicine
  31. Hypertension in Diabetes: Treatment Considerations
    Mariela Glandt, Zachary T. Bloomgarden · 2011 · Journal of Clinical Hypertension
  32. "Glycemic variability": a new therapeutic challenge in diabetes the critical care setting
    Antonio Ceriello · 2010 · Avances en Diabetología
  33. Strategies to enhance cardiovascular disease prevention in patients with diabetes
    Matteo Anselmino, Lars Rydén · 2009 · Current Opinion in Cardiology
  34. Serum Levels of Heat Shock Protein 27 as a Potential Marker of Diabetic Nephropathy in Egyptians with Type 2 Diabetes
    Shahenda Mahgoub, Mаhmoud Youns, Atef Bassyouni, Zeinab Korany Hassan · 2012
  35. Patient expectations of hypertension and diabetes medication: Excessive focus on short-term benefits
    Demetra S Gibson, Aviva G. Nathan, Michael T. Quinn, Neda Laiteerapong · 2018 · SAGE Open Medicine
  36. Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project
    Hirotoshi Ohmura, Tomoya Mita, Joe Matsuoka, Shuko Nojiri, Yuji Nishizaki, Hirotaka Watada, Hiroyuki Daida, SPIRITS-J Study Investigators · 2019 · Diabetes Therapy
  37. Epidemiology, Risk Factors, and Pathophysiology of Diabetic Retinopathy
    Neelakshi Bhagat, Marco A. Zarbin · 2018 · Springer eBooks
  38. What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?
    Alejandro de la Sierra, Jorge Brenes Salazar · 2011 · Advances in Therapy
  39. Strategies to alter the trajectory of atherosclerotic cardiovascular disease
    Chris J. Packard · 2019 · Current Opinion in Lipidology
  40. Factors associated with blood pressure control in diabetic patients treated in nephrology units. PRESDIAB Study.
    Núria Serra, Anna Oliveras, Salvador Bergoñón, Laia Sans, A Cobos, P Martínez, Remei Artigas, Esteban Poch · 2011 · PubMed
  41. Prediction of near-future HbA1c levels using glycated albumin levels before and after glimepiride administration for 2 weeks is useful to determine the effectiveness of the treatment
    Masafumi Koga, Jun Murai, Hiroshi Saito, Soji Kasayama · 2012 · Diabetology International
  42. Blood pressure 2 years after a chronic disease management intervention study
    Sheldon W. Tobe, Lloyd Vincent, Joan Wentworth, Denise Hildebrandt, Alexander Kiss, Nancy J. Perkins, Susan Hartman, Laurie Ironstand, Jacquie Hoppe, Katie Hunter et al. · 2010 · International Journal of Circumpolar Health
  43. Fenofibrate and risk of minor amputations in diabetes
    Sergio Fazio, MacRae F. Linton · 2009 · The Lancet
  44. The Benefits and Concerns Surrounding the Automation of Clinical Guidelines
    Samuel Cykert · 2015 · North Carolina Medical Journal
  45. IDegAsp (insulin degludec + insulin aspart) for the management of type 2 diabetes: current status
    Jens Sandahl Christiansen, Philip Home, Ajay Kumar · 2016 · Expert Review of Endocrinology & Metabolism
  46. Strategies to meet the need for long-term data
    John Philip Chalmers, Mark Woodward, Claudio Borghi, Athanasios John Manolis, Giuseppe Mancia · 2016 · Journal of Hypertension
  47. Pharmacologic Management of Hypertension
    Joseph J. Saseen · 2012 · Elsevier eBooks
  48. A Case Report of Diabetic Neuropathy Treated with Korean Medicine
    Jung-hwa Yoo, Da-eun Lee, Dong-hyun Kim, Se-young Ahn, Byung-cheol Lee, Young-min Ahn · 2017 · The Journal of Internal Korean Medicine
  49. Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion
    Aowen Zhuang, Felicia Y. T. Yap, Domenica A. McCarthy, Sherman S. Leung, Sally A. Penfold, Chris Leung, Karly C. Sourris, Brooke E. Harcourt, Vicki Thallas‐Bonke, Melinda T. Coughlan et al. · 2019 · Scientific Reports
  50. Low circulating arachidonic acid is associated with macroalbuminuria in diabetic patients: a cross-sectional examination of the KAMOGAWA-DM cohort study
    Takuro Okamura, Hanako Nakajima, Yoshitaka Hashimoto, Saori Majima, Takafumi Senmaru, Emi Ushigome, Naoko Nakanishi, Masahide Hamaguchi, Mai Asano, Masahiro Yamazaki et al. · 2021 · BMC Nephrology
  51. Arterial Hypertension
    Francesco Paneni, Francesco Cosentino · 2015 · Springer eBooks
  52. Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes
    Luke Joseph Laffin, George L. Bakris · 2018 · Diabetes Obesity and Metabolism
  53. Disease progression in newly diagnosed Type 2 Diabetes Mellitus patients: a statistical analysis using Clinical Practice Research Datalink (CPRD)
    Thomas Gijo · 2015 · The University of Queensland
  54. Nutrition Aspects of Stroke Prevention
    Katherine Patton, Mandy L. Corrigan · 2015 · Springer eBooks
  55. Management of Type 2 Diabetes Mellitus
    Leslie Bahn Kawa · 2023 · IntechOpen eBooks
  56. ‘Memory’ and ‘legacy’ in hypertension and lifestyle-related diseases
    Hiroyuki Sasamura, Hiroshi Itoh · 2012 · Hypertension Research
  57. Trials of cardiovascular risk factor management in type 2 diabetes
    Anushka A Patel, Rohina Joshi, Bastiaan E. de Galan · 2009 · Current Opinion in Cardiology
  58. Type 2 Diabetes Mellitus Complicated by Hypertension in Japanese Patients: Switching Treatment from High-dose Angiotensin II Receptor Blockers to Losartan Plus Hydrochlorothiazide
    Sunao Yamamoto, Yosuke Okada, Hiroko Mori, Keiko Nishida, Kohei Uriu, Yoshiya Tanaka · 2014 · Internal Medicine
  59. Is there an elephant in the room?
    Jonathan Richards · 2009 · British Journal of General Practice
  60. Effects of intraoperative administration of carbohydrates during long-duration oral and maxillofacial surgery on the metabolism of carbohydrates, proteins, and lipids
    Toru Yamamoto, Mitsuhiro Yoshida, Seiji Watanabe, Hiroshi Kawahara · 2015 · Oral and Maxillofacial Surgery
  61. What changes in inflammatory bowel disease management can be implemented today?
    Edouard J. Louis, Daniel C. Baumgart, Subrata K. Ghosh, Fernando Gomollón, Stephen B. Hanauer, Ailsa L Hart, Peter Miles Irving · 2012 · Journal of Crohn s and Colitis
  62. Antihypertensive Drugs and Diabetic Retinopathy in Patients with Type 2 Diabetes
    Jen-Chieh Lin, Mei‐Shu Lai · 2015 · Ophthalmologica
  63. Factors associated with attendance at clinical follow-up of a cohort with screen-detected type 2 diabetes: ADDITION-Denmark
    Annette Danielsen Jensen, Signe T. Andersen, Morten Charles, Lasse Bjerg, Daniel R. Witte, Bibi Gram, Marit E. Jørgensen, Annelli Sandbæk, Else‐Marie Dalsgaard · 2019 · Primary care diabetes
  64. Effect modification of hyperlipidemia and hypertension on the association between type 2 diabetes and gout
    Yi-Ching Tung, Mei‐Yueh Lee, Yi‐Chi Wang, Chai‐Jan Chang, Wen‐Chan Tsai, Gau‐Tyan Lin, Chia‐Yang Li, Su‐Shin Lee, Hung‐Pin Tu · 2020 · Primary care diabetes
  65. Clinical Perspective on the Management of Hypertension
    Muzaffar Iqbal · 2011 · Indian journal of clinical medicine
  66. Prise en charge du diabète de type 2 : anciens ou nouveaux médicaments, comment choisir ?
    S. Halimi · 2013 · La Presse Médicale
  67. Glycemic Control in Older Adults: Applying Recent Evidence to Clinical Practice
    Anil K. Sood, David Clark Aron · 2009
  68. Diabetic Kidney Disease
    Mark E. Williams, Robert C. Stanton · 2010 · Elsevier eBooks
  69. Intensive vs. conventional blood pressure goals in older patients with type 2 diabetes: a systematic review and meta-analysis
    René Rodríguez‐Gutiérrez, Andrea Flores-Rodríguez, Karina Raygoza-Cortez, Mariana García-Leal, Sofía Mariño-Velasco, Hiram H. Plata-Huerta, Melissa Sáenz-Flores, Luz Angélica Ramírez-García, Amanda Rojo‐Garza, Spyridoula Maraka et al. · 2022 · Endocrine
  70. Remodeling is at the heart of chromatin
    Assam El‐Osta · 2011 · Epigenetics
  71. How information about the time requirements and legacy effects of treatments influence decision-making in patients with diabetes and hypertension
    Neda Laiteerapong, Paige C. Fairchild, Aviva G. Nathan, Michael T. Quinn, Elbert S. Huang · 2016 · BMJ Open Diabetes Research & Care
  72. The Management of Post-prandial Glucose
    Antonio Ceriello · 2008 · US Endocrinology
  73. Statin therapy reduces the likelihood of suboptimal blood pressure control among Ugandan adult diabetic patients
    William Lumu, Leaticia Kampiire, George Patrick Akabwai, Daniel Ssekikubo Kiggundu, Davis Kibirige · 2017 · Therapeutics and Clinical Risk Management
  74. Managing Cardiovascular Complications in Diabetes
    John D. Betteridge, Stephen James Nicholls · 2014 · Wiley eBooks
  75. Synthesis andIn VivoEvalution of Decursinol Derivatives as Antidiabetics
    Jeongho Joo, Ho‐Seok Kwon, Jiseok Lee, Kook Hyun Yu · 2017 · Bulletin of the Korean Chemical Society
  76. Palliative radiotherapy utilization within a regional Australian palliative care unit
    Peter Eastman, Anna Dowd, James Goonan, Helen M. Farrell, Graham Pitson · 2017 · Annals of Palliative Medicine
  77. Identification of population characteristics through implementation of the Comprehensive Diabetic Retinopathy Program
    Nish Patel, Lilia Verchinina, Michele Wichorek, Thomas W. Gardner, Dorene S. Markel, Jennifer Wyckoff, Anjali R. Shah · 2019 · Clinical Diabetes and Endocrinology
  78. Association between hemoglobin A1c and acute ischemic stroke among patients with type-2 diabetes: a case-control study
    Wisit Chaveepojnkamjorn, Wandee Boorasri, Chukiat Viwatwongkasem, Sukontha Siri, Warakorn Krienkaisakda · 2020 · International Journal of Diabetes in Developing Countries
  79. An Insight into the Development of Potential Antidiabetic Agents along with their Therapeutic Targets
    Siddhita Tiwari, Paranjeet Kaur, Deepali Gupta, Saumik Chaudhury, Manish Chaudhary, Amit Mittal, Shubham Kumar, Sanjeev Kumar Sahu · 2023 · Endocrine Metabolic & Immune Disorders - Drug Targets
  80. Reverse Translational Study of Fenofibrate's Observed Effects in Diabetes‐Associated Retinopathy
    RA Farris, ET Price · 2016 · Clinical and Translational Science
  81. Epidemiologic Characterization of Risk for Cardiovascular Diseases
    Kevin Carl Maki, Mary R. Dicklin, Kristin M. Nieman · 2018 · Contemporary cardiology
  82. For debate; pharmacological priorities in advanced type 2 diabetes
    Israel Hodish · 2019 · Journal of Diabetes and its Complications
  83. Behandlungsziele bei Bluthochdruck und Diabetes mellitus
    Christos Chatzikyrkou, Hermann G. Haller, Jan Menne · 2012 · Der Internist
  84. Circulating biomarkers of diabetic retinopathy: a systematic review and meta-analysis
    Annie K. McAuley, Paul Gerard Sanfilippo, Paul Connell, Jie Jin Wang, Mohamed Dirani, Ecosse Luc Lamoureux, Alex William Hewitt · 2012 · Diabetes Management
  85. Antihypertensive treatment in diabetic patients. Review of current data
    Georgia Argyrakopoulou, Costas P. Tsioufis, Eleni Sdraka, Dimitris Tsiachris, Konstantinos Makrilakis, Christodoulos Stefanadis · 2013 · Maturitas
  86. Intensive Glycemic Control and Macrovascular Disease in Type 2 Diabetes – A Report on the 44th Annual EASD Meeting, Rome, Italy, September 2008
    Tapani Rönnemaa · 2008 · The Review of Diabetic Studies
  87. Cardiovascular Risk in Hypertension – Can We Ask for More?
    Massimo Volpe · 2008 · High Blood Pressure & Cardiovascular Prevention
  88. The ACCORD Study: The Devil Is in the Details
    David Siegel, Arthur Swislocki · 2010 · Metabolic Syndrome and Related Disorders
  89. Diabetic Nephropathy
    Sally M. Marshall, Allan Flyvbjerg · 2010
  90. Impact of virtual patient engagement on glycemic control in type 2 diabetes: a retrospective observational study from GluCare hybrid care model
    Hala Zakaria, Geethu Paul, Joelle Debs, Juman Ali, Adam Almarzooqi, ALI HASHEMI, Ihsan Almarzooqi · 2025 · Frontiers in Endocrinology
  91. Nichtmedikamentöse und medikamentöse Therapie bei arterieller Hypertonie
    Joachim D. Hoyer · 2012 · Herz
  92. Management of Cardiovascular Disease in Women
    Mieszczanska, Hanna Z, Velarde, Gladys P · 2014 · Springer eBooks
  93. ¿Controlamos correctamente la diabetes desde atención primaria en Talavera de la Reina (Toledo)?
    Juan José Criado‐Álvarez, Juan Carlos Méndez-Cabeza Fuentes, Fernando Bustos Guadaño · 2011 · Medicina de Familia SEMERGEN
  94. The Unholy Alliance between Obesity, Type-2 Diabetes, the Sympathetic Nervous System, and Hypertension in Young/Middle-Aged Subjects
    JM Cruickshank · 2014 · Journal of Molecular and Genetic Medicine
  95. The Pathobiology of Diabetes Mellitus
    Alicia Josephine Jenkins, David Norman O'Neal, Christopher James Nolan, Andrzej S. Januszewski · 2016 · Stem cell biology and regenerative medicine
  96. Intensive Blood Pressure Control in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cardiovascular and Microvascular Outcomes
    Asma Mousavi, Shayan Shojaei, Amir Parsa Abhari, Seyed Alireza Mirhosseini, Rasoul Ebrahimi, Erta Rajabi, Mashood Ahmad Farooqi, Amirali Azizpour, Shiva Armani Moghadam, Toshiki Kuno et al. · 2025 · American Journal of Hypertension
  97. CT Imaging in the Carotid Artery
    Luca Saba · 2010 · Springer eBooks
  98. How good are GPs at adhering to a pragmatic trial protocol in primary care? Results from the ADDITION-Cambridge cluster-randomised pragmatic trial
    Michael Laxy, Ed Wilson, Clare E. Boothby, Simon J. Griffin · 2018 · BMJ Open
  99. Diabetic cardiomyopathy: a review of literature on clinical status and meta-analysis of tissue doppler diagnostic method and the clinical value of intensive glycemic control
    Aref Albakri · 2018 · Medical and Clinical Archives
  100. IN VIVO AMELIORATIVE POTENTIAL OF CAFFEIC ACID AGAINST HEPATOTOXICITY AND NEPHROTOXICITY INDUCED BY MERCURIC CHLORIDE IN ALBINO WISTAR RATS
    MANOGARAN MANJU, Ganesan Jagadeesan · 2019 · Asian Journal of Pharmaceutical and Clinical Research